 |
text only |
|
|||||||||||||||||||||||||||||
| Roger Ove, M.D., Ph.D. |
|
||
|
Vice Chair, Department of Radiation Oncology Philip Rubin Professor of Interdisciplinary Oncology |
|||
|
Roger Ove M.D., Ph.D. is the Vice Chair of the Department of Radiation Oncology and Philip Rubin Professor of Interdisciplinary Oncology at the Mitchell Cancer Institute. He has an active clinical practice, but also has a keen interest in the design and conduct of translational clinical research incorporating technology to improve delivery of radiation in the treatment of cancer. Dr. Ove graduated in 1980 from the University of Pittsburgh with a Bachelor of Science degree in physics and mathematics. He went on to pursue his PhD in physics at Yale University and upon graduation worked as an Associate Research Scientist at the National Center for Supercomputing Applications at the University of Illinois, Urbana-Champaign. While there, he also taught as a visiting assistant professor in the Department of Astronomy and in 1991 made the decision to pursue a degree in medicine. Graduating from the University of Illinois at Urbana-Champaign College of Medicine in 1995, Dr. Ove fulfilled his internship in internal medicine at the Yale University-affiliated Hospital of Saint Raphael in New Haven, Connecticut. Integrating his earlier academic interests with his medical training, Dr. Ove completed his residency in radiation oncology at the University of Maryland in Baltimore where he served as Chief Resident in 1999. In 2000 Dr. Ove was recruited to the South and joined the Department of Radiation Oncology at the University of Alabama, Birmingham where he served as an Assistant Professor for the next five years. Since that time, Dr. Ove has held faculty positions at the University of Tennessee College of Medicine, the East Carolina University Brody School of Medicine, and has been a member of the University of North Carolina Lineberger Comprehensive Cancer Center before joining the MCI in 2010. Dr. Ove has a special interest in the treatment of head and neck, genitourinary, and central nervous system malignancies. Focusing on the molecular aspects of cancer therapy, he has a specific interest in interactions between radiation and systemic treatments. Board certified by the American Board of Radiology, he is trained in a number of special procedures, including Tomotherapy, Cyberknife stereotactic intracranial and extracranial radiosurgery, image-guided radiotherapy, intensity-modulated radiotherapy, and brachytherapy for prostate as well as breast cancer. He has authored numerous scholarly articles and has served as a Head and Neck Cancer Professor for the American Society for Therapeutic Radiology and Oncology (ASTRO). As principal investigator on numerous grants, both private and public, Dr. Ove has had a prolific publishing history and continues to actively contribute to his specialized field. During his spare time he enjoys golfing, water sports and fishing, and spending time with his family. |
|||
|
||||||
